Search
Professor Andrew Whitehouse awarded the most prestigious award in the country for young researchers – the 3M Eureka Prize for Emerging Leader in Science.
A new study led by The Kids Research Institute Australia has found a link between masculine facial features and autism.
Professor Andrew Whitehouse has been awarded an Autism Spectrum Australia Recognition Award for his work communicating scientific findings to families.
Andrew Whitehouse has been listed in the WA Business News 40 under 40 awards recognising accomplished and dynamic young leaders in Western Australia.
Researchers have shown that the so called 'autism epidemic' is due to an increase in the diagnosis of children with less severe behavioural symptoms.
Andrew Kandice Matt Melissa Videos Whitehouse Watch and listen to Andrew Varcin Cooper Licari PhD M.Psych (Clinical), PhD BCA Marketing, BSc
Having a child on the autism spectrum (AS) is known to impact caregiver quality of life (QoL), time use, and stress. A co-occurring diagnosis of intellectual disability (ID) is common among children on the autism spectrum, with ID itself impacting caregiver outcomes. This study sought to understand how co-occurring ID in children on the autism spectrum may influence caregiver-related outcomes. Secondary analysis of survey data from caregivers of 278 children on the autism spectrum with (n = 62) and without (n = 216) co-occurring ID was conducted, exploring impacts on caregiver QoL, stress, coping, and time-use.
The Kids' autism research takes place at CliniKids, a centre that integrates world-class research with a clinical service for children with developmental delay and/or autism and their families.
The placebo effect is established in clinical trials, but for paediatric research, questions remain about how to best manage its influence. Within the autism field, data on these issues is sparse. This is particularly important in the oxytocin field where placebo responses are thought to play an important role. This study reports on data from the single-blind, placebo lead-in phase of a randomised controlled trial to investigate the placebo response and its relationship to treatment response in autistic children.
Autistic children demonstrate an increased likelihood of self-injurious behaviours (SIB). To support autistic individuals who exhibit SIB and understand the factors that contribute to SIB, we examined several child and family characteristics associated with the severity of SIB.